Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 074703
Company: PHARMOBEDIENT CNSLTG
Company: PHARMOBEDIENT CNSLTG
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METOCLOPRAMIDE HYDROCHLORIDE | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE/5ML | SOLUTION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/31/1997 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/08/2014 | SUPPL-10 | Labeling-Medication Guide |
Label is not available on this site. |
||
02/15/2011 | SUPPL-9 | Labeling-Package Insert |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/074703s009ltr.pdf |
02/17/2011 | SUPPL-8 | Labeling |
Label is not available on this site. |
||
09/15/2009 | SUPPL-7 | Labeling, REMS-Proposal |
Letter (PDF)
Review (PDF) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/074703s007ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/anda/2009/074703Orig1s007.pdf |
06/30/2009 | SUPPL-6 | Labeling, REMS-Proposal |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/anda/2009/074703Orig1s006.pdf |
05/16/2012 | SUPPL-5 | Labeling |
Label is not available on this site. |
||
08/18/2003 | SUPPL-4 | Labeling |
Label is not available on this site. |
||
07/12/2002 | SUPPL-3 | Labeling |
Label is not available on this site. |
||
12/20/2001 | SUPPL-2 | Labeling |
Label is not available on this site. |
||
09/21/2000 | SUPPL-1 | Manufacturing (CMC) |
Label is not available on this site. |